Treating exuberant, non-resolving inflammation in the lung; Implications for acute respiratory distress syndrome and COVID-19

While COVID-19, the disease driven by SARS-CoV-2 has ignited interest in the host immune response to this infection, it has also highlighted the lack of treatment options for the damaging inflammatory responses driven by pathogens that precipitate the acute respiratory distress syndrome (ARDS). With...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Pharmacol Ther
Hlavní autoři: Gilroy, Derek W., De Maeyer, Roel P.H., Tepper, Mark, O’Brien, Alastair, Uddin, Mohib, Chen, Judy, Goldstein, Daniel R., Akbar, Arne N.
Médium: Artigo
Jazyk:Inglês
Vydáno: Published by Elsevier Inc. 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7657264/
https://ncbi.nlm.nih.gov/pubmed/33188794
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pharmthera.2020.107745
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky